Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the ClinicalTrials.gov navigation, linking to transition updates and describing a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T06:58:18.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T06:30:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T08:11:17.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Updated page to Revision: v3.7.0. Sponsor branding and links to study documents, IPD sharing information, and related resources were removed from the study record.
    Difference
    19%
    Check dated 2026-09-20T03:22:55.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Added a U.S. NIH grant/contract identifier for the study and updated the site revision to v3.6.6, while the previous revision entry v3.6.5 was removed.
    Difference
    0.0%
    Check dated 2026-08-29T23:51:28.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Revision identifier updated from v3.6.4 to v3.6.5, indicating a new version of the document. This metadata update suggests a small update to the page or its supporting materials without changing the visible content.
    Difference
    0.0%
    Check dated 2026-08-08T22:31:24.000Z thumbnail image

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.